GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (XCNQ:BETR) » Definitions » Net Interest Income (for Banks)

BetterLife Pharma (XCNQ:BETR) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is BetterLife Pharma Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


BetterLife Pharma Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Steven Sangha 10% Security Holder
Ahmad Doroudian Director, Senior Officer
Robert Metcalfe Director
James Russell Starr Senior Officer